CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Tianjin Chase Sun Pharmaceutical Company Limited Company Snapshot
Tianjin Chase Sun Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Tianjin Chase Sun Pharmaceutical Company Limited with three other companies in this sector in China: Shenzhen Salubris Pharmaceuticals Co Ltd (2015 sales of 3.48 billion Chinese Renmimbi [US$503.95 million] of which 100% was Pharmaceutical Manufacturing), Guizhou Yibai Pharmaceutical Co., Ltd. (3.30 billion Chinese Renmimbi [US$478.57 million] of which 14% was Medicine), and Jinling Pharmaceutical Company Limited (3.22 billion Chinese Renmimbi [US$466.45 million] of which 72% was Medicine Manufacture).

Sales Analysis. During the year ended December of 2015, sales at Tianjin Chase Sun Pharmaceutical Company Limited were 3.35 billion Chinese Renmimbi (US$485.19 million). This is an increase of 16.9% versus 2014, when the company's sales were 2.86 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Tianjin Chase Sun Pharmaceutical Company Limited (and since 2010, sales have increased a total of 772%). Sales of Other Main Operation saw an increase that was more than double the company's growth rate: sales were up 4,920.9% in 2015, from 70,058.52 Chinese Renmimbi to 3.52 million Chinese Renmimbi. Tianjin Chase Sun Pharmaceutical Company Limited also saw significant increases in sales in Granules (up 30.5% to 1.59 billion Chinese Renmimbi) and Medical Devices (up 183.3% to 63.87 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Tianjin Chase Sun Pharmaceutical Company Limited
  Stock Performance Chart for Tianjin Chase Sun Pharmaceutical Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 5.28
(Figures in Chinese Renmimbi)
1 Week -3.1%   13 Weeks -5.5%  
4 Weeks -17.4%   52 Weeks 2.4%  
 
Tianjin Chase Sun Pharmaceutical Company Limited Key Data:
  Ticker: 300026 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 3,348,232,255
(Year Ending Jan 2016).
Employees: 5,183
  Currency: Chinese Renmimbi Market Cap: 15,900,172,691
  Fiscal Yr Ends: December Shares Outstanding: 3,011,396,343
  Share Type: A Gu Closely Held Shares:
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.